Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
107.2 USD | -0.33% | +0.10% | -2.63% |
04:21pm | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
04-26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.63% | 187B | |
-1.94% | 106B | |
-4.44% | 66.9B | |
+0.86% | 49.45B | |
+16.74% | 48B | |
+4.06% | 40.84B | |
+3.38% | 26.48B | |
+0.72% | 26.25B | |
+12.96% | 24.62B | |
-0.16% | 24.52B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- US to Require Insurers to Pay for At-Home COVID-19 Tests